POLY MEDICURE
Back to Cashflow Statement
|
POLY MEDICURE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹951 Cr | ₹-20 Cr | ₹-13 Cr | ₹-35 Cr | ₹317 Cr |
What is the latest Cash Flow from Financing Activities ratio of POLY MEDICURE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹951 Cr |
| Mar2024 | ₹-20 Cr |
| Mar2023 | ₹-13 Cr |
| Mar2022 | ₹-35 Cr |
| Mar2021 | ₹317 Cr |
How is Cash Flow from Financing Activities of POLY MEDICURE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹951 Cr | Positive | |
| Mar2024 | ₹-20 Cr | Negative | |
| Mar2023 | ₹-13 Cr | Negative | |
| Mar2022 | ₹-35 Cr | Negative | |
| Mar2021 | ₹317 Cr | - | |
Compare Cash Flow from Financing Activities of peers of POLY MEDICURE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| POLY MEDICURE | ₹16,211.3 Cr | 10.2% | 8.6% | -36.5% | Stock Analytics | |
| LENSKART SOLUTIONS | ₹89,335.5 Cr | 7.9% | -5.5% | NA | Stock Analytics | |
| LAXMI DENTAL | ₹1,368.0 Cr | 25.6% | 28.1% | -48.6% | Stock Analytics | |
| 3B BLACKBIO DX | ₹1,029.2 Cr | -7.1% | -11.4% | -29.2% | Stock Analytics | |
| PREVEST DENPRO | ₹473.9 Cr | -0.3% | -9.1% | -20.4% | Stock Analytics | |
| NURECA | ₹258.9 Cr | 0.2% | 1.7% | 8.7% | Stock Analytics | |
POLY MEDICURE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| POLY MEDICURE | 10.2% |
8.6% |
-36.5% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses